A cute respiratory distress syndrome (ARDS) is a life-threatening form of injury to the lung caused by a variety of underlying diseases and affecting between 100,000 and 200,000 Americans each year (1) . Despite being relatively common and carrying a mortality of 30% to 60%, ARDS remains a heterogeneous clinical syndrome that is not easily defined or diagnosed (1) (2) (3) . A formal description of the syndrome was established in 1994 by the American-European Consensus Conference (AECC) (4) . The AECC defined ARDS as 1) bilateral infiltrates on chest radiograph consistent with pulmonary edema; 2) PaO 2 /FIO 2 ratio Ͻ200; and 3) absence of left atrial hypertension. This definition remains the most widely accepted description of the disease (5) .
The hallmark of ARDS is proteinrich pulmonary edema resulting from disruption of the alveolar capillary barrier and a decrease in net alveolar fluid clearance (5) (6) (7) (8) . This pathologic accumulation of pulmonary edema can be quantified as extravascular lung water (EVLW). Although the physiologic derangements in ARDS necessarily lead to elevated EVLW, it is not part of the diagnostic criteria for ARDS. Previous studies using single-indicator thermodilution have noted that 21% to 35% of clinical ARDS patients have normal EVLW (defined as Ͻ10 mL/kg) (9 -12) . The reason for this inconsistency has not been determined.
EVLW is calculated as milliliters per kilogram and historically is indexed to the actual body weight of the patient at the time of measurement. No scientific justification or clinical validation for indexing to actual body weight exists. Height and gender are known to be the most important factors in determining lung volumes (13, 14) , and excess body weight does not appreciably change functional lung volumes. As more than half of ARDS patients are overweight (15) , EVLW may be better represented by height-based calculations. If true, then indexing EVLW to actual body weight may not accurately depict the presence of pulmonary edema inherent to ARDS. We hypothesize that using patient height to calculate EVLW will more accurately characterize EVLW than current methodology, which may be important for both prognosis and institution of appropriate therapy.
MATERIALS AND METHODS
This study was reviewed and approved by the Institutional Review Board at Emory University School of Medicine and the Research Oversight Committee of Grady Memorial Hospital. Study participants were medical and surgical intensive care unit (ICU) patients at two large academic hospitals in Atlanta, GA (Grady Memorial Hospital and Emory Crawford Long Hospital). All ICU patients were screened for eligibility, and participation was solicited within 72 hrs for patients meeting the AECC definition of ARDS as described previously. Exclusion criteria included contraindication to femoral artery catheterization, cause of ARDS Ͼ10 days before eligibility, Pneumocystis carinii pneumonia, pneumonectomy, age Ͻ18 yrs, pregnancy, or inability to obtain consent from patient or surrogate. After informed consent, patient-specific data were obtained, such as medical, social, and surgical history; risk factors for ARDS; Acute Physiology and Chronic Health Evaluation II score; Lung Injury Score (LIS) (16) ; and standard laboratory values. A cohort of severe sepsis patients (American College of Chest Physicians/Society of Critical Care Medicine consensus definition) (17) at risk for but not meeting the AECC definition for ARDS were simultaneously enrolled and used for comparison.
Once a patient was enrolled, a 5-Fr arterial catheter (Pulsiocath PV2015L20; Pulsion Medical Systems, Munich, Germany) was inserted into the descending aorta via the femoral artery using the Seldinger technique. A temperature sensor was connected to the distal port of a standard central venous catheter in either the internal jugular or subclavian location. The arterial and central venous catheters were connected to an integrated bedside monitor (PiCCO, Pulsion Medical Systems) for continuous hemodynamic monitoring. All patient management decisions, including fluid and ventilator management, were made by the primary intensive care physicians caring for the patient.
Measurements of Extravascular Lung Water. The PiCCO catheter system operates via a single thermal indicator technique to determine EVLW, cardiac output, and volumetric variables. Cardiac output and EVLW measurements were obtained by triplicate central venous injections of 15-20 mL of iced (Ͻ8°C) 0.9% saline and recorded as the mean of the three measurements. Iced saline was injected into the central venous catheter while the thermistor tip on the femoral artery catheter measured the downstream temperature change within the abdominal aorta. Cardiac output was then calculated by analysis of the temperature change of the thermodilution curve using the Stewart-Hamilton method. This has been shown to be comparable to pulmonary artery thermodilution (18, 19) . Volumetric variables were derived using cardiac output, mean transit time of the thermal indicator, and decay time of the thermodilution curve, as previously described (9, 20, 21) . EVLW represents all fluid that diffuses and remains outside of the pulmonary vasculature during transit of the thermal indicator (i.e., summation of interstitial, intracellular, and alveolar fluid); its derivation has been described in detail previously (20 -22) . All volumetric and hemodynamic variables were indexed to body surface area, except for EVLW and central venous pressure. Measurements were obtained immediately after catheter insertion and at least once every 24 hrs for a period of 7 days. The catheter system was discontinued before 7 days in the event of patient transfer out of the ICU or death.
Outcome Variables. Patients were classified as having elevated EVLW if any measurement of EVLW was Ͼ10 mL/kg during the study period. This value is based on previous studies of EVLW in animal models without evidence of lung injury (23) (24) (25) and has been established as a threshold for acute lung injury in previous clinical studies (9, 26, 27) . All measurements of EVLW were initially recorded as absolute, unindexed values, which were then divided by actual body weight, predicted body weight, or adjusted body weight to obtain specific indexed values. Actual body weight was obtained at time of enrollment into study by duplicate measurement using a patient bed scale. The majority of patients were weighed on a Hill-ROM Century CC hospital bed, which has a maximal weight of 136 kg and accuracy of Ϯ1%. Patient height was recorded by duplicate measurements using a flexible tape measure and corroborated by selfreported patient height from admission paperwork when available.
Patient weight (kg) was calculated using the following formulas (28, 29 (30); this formula is also frequently referred to as ideal body weight. We have selected the nomenclature predicted body weight to be consistent with recent ARDS clinical trials (28, 31) .
Patients were followed until time of hospital discharge to determine duration of mechanical ventilation, hospital length of stay (LOS), and in-hospital mortality. Severity of ARDS was quantified by the LIS (16), PaO 2 /FIO 2 ratio, positive end-expiratory pressure, and static lung compliance. As ARDS is a dynamic process, a daily assessment of patients was performed to confirm whether they met the AECC criteria for ARDS on the same day that an EVLW measurement was recorded. This variable is referred to as daily ARDS in the data analysis. All radiographs were interpreted by experienced critical care physicians. 
RESULTS
Study Population. Forty-four patients were enrolled from July 2001 to December 2006. Thirty patients (68% of study population) with clinically diagnosed ARDS were prospectively enrolled within 72 hrs of meeting AECC definition. The remainder of enrolled patients (n ϭ 14) had severe sepsis but did not meet criteria for ARDS. One patient was originally enrolled with severe sepsis only but developed ARDS on study day 2. This patient was included in the ARDS cohort, using data starting at day 2 and continuing for a total of 8 days. Twenty-five (56%) patients completed all 7 days of the study. The study was terminated early in 19 patients (44%) due to patient death (n ϭ 8), transfer out of ICU (n ϭ 8), central catheter discontinuation (n ϭ 1), or study catheter malfunction (n ϭ 2). Patients not completing 7 days of the study had all data up to the time of discontinuation included in analysis. A total of 237 study days were available for analysis. Twelve measurements of EVLW were missing and were not imputed; therefore, 225 independent determinations of EVLW were made during the study period (mean 5.1 measurements per patient).
The average age of study participants was 51 yrs, with a majority of patients (84%) being African American. Sepsis was the primary cause of ARDS in 22 (73%) patients. Other risk factors for development of ARDS included pneumonia (n ϭ 5), trauma (n ϭ 1), pancreati-tis (n ϭ 1), and aspiration (n ϭ 1). Fourteen patients (47%) had extrapulmonary causes for ARDS. The sources of non-ARDS sepsis included pneumonia (n ϭ 5), primary bloodstream infection (n ϭ 4), urinary system infection (n ϭ 2), and intra-abdominal infection (n ϭ 3). The mean Acute Physiology and Chronic Health Evaluation II score was 25.8, and overall mortality was 45.5%. Chronic alcohol abuse was present in 19 of 44 patients (43%), and HIV infection was present in 13 (30%) patients. At the time of enrollment, ARDS patients were taller (mean ϭ 174.5 cm) and weighed more (mean actual body weight 83.5 kg) than non-ARDS severe sepsis patients (166 cm and 70.5 kg, respectively). This baseline imbalance produced a disparity in calculated body weight between the ARDS and non-ARDS patients. Baseline characteristics, including demographic and physiologic variables, are included in Table 1 .
As seen in Table 2 , hemodynamic measurements were similar between ARDS and non-ARDS patients with no significant differences in mean study values of cardiac index, systemic vascular resistance index, global end-diastolic volume index, and intrathoracic blood volume index. Fluid balance (net input minus output) was consistently positive and not significantly different in both ARDS and non-ARDS patients, with a daily mean fluid balance of 2.1 Ϯ 2.8 L. ICU LOS was longer in the ARDS group (20 days vs. 11 days, p ϭ .02), as was the duration of mechanical ventilation (17 days vs. 9 days, p ϭ .05). Hospital LOS (mean 30 days) and overall mortality (45.5%) were not significantly different between ARDS and non-ARDS patients.
Indexing EVLW Measurements to Body Weight. There were 164 individual measurements of EVLW in ARDS patients (123 daily ARDS measurements) and 61 measurements in non-ARDS sepsis patients. Mean EVLW indexed to actual body weight was 12.7 for ARDS patients and 7.8 for non-ARDS sepsis patients (p Ͻ .0001). Mean EVLW increased for both ARDS and non-ARDS sepsis patients when EVLW was indexed to PBW or adjusted body weight (AdjBW) as demonstrated in Figure 1 . When we used actual body weight to determine EVLW, seven of 30 (23%) ARDS patients had normal EVLW (Ͻ10 mL/kg) throughout the study, and six of 14 (43%) non-ARDS sepsis patients had normal EVLW throughout the study. In ARDS patients, 45 of 123 (37%) daily ARDS measurements were normal, and in non-ARDS sepsis patients, 46 of 61 (75%) of measurements were normal when EVLW was indexed to actual body weight (ActBW). In all patients, EVLW increased by an average of 1.1 Ϯ 2.1 mL/kg when indexed to AdjBW and 2.0 Ϯ 4.1 mL/kg when indexed to PBW. The absolute change in EVLW was similar between patients with or without ARDS. By indexing EVLW to PBW or AdjBW, all but one patient with ARDS (97% of all ARDS patients) had at least one elevated measurement of EVLW, whereas more non-ARDS sepsis patients had normal EVLW measurements (50% of non-ARDS sepsis patients). The proportion of ARDS patients with elevated EVLW was significantly greater when indexed to PBW or AdjBW compared with ActBW (each p Ͻ .05) ( Table 3 ).
Multivariate linear regression was performed to adjust for baseline differences in age, ActBW, and height between ARDS and non-ARDS sepsis patients. After adjustment for age, ActBW, and height, 97% of ARDS patients had elevated EVLW when indexed to AdjBW and 93% when indexed to PBW. This was not significantly different from the unadjusted measurements (97%, p not significant) reported previously. The percentage of non-ARDS sepsis patients with normal EVLW when indexed to PBW or AdjBW was not significantly affected by adjustment for baseline differences in age, actual body weight, and height.
Correlation 
DISCUSSION
Extravascular lung water is a useful method to quantify the accumulation of parenchymal lung edema. Its measurement is more sensitive than chest radiograph (33, 34) and more accurate than pulmonary artery occlusion pressure at estimating nonhydrostatic edema in patients with ARDS (35) . By current convention, measurements of EVLW are indexed to ActBW, despite a lack of scientific basis or clinical validation. In this study, we found that indexing EVLW to PBW or AdjBW increased the propor- EVLW calculated using predicted body weight (PBW) and adjusted body weight (AdjBW) compared to actual body weight (ActBW) results in significantly more acute respiratory distress syndrome (ARDS) patients with elevated EVLW (Ͼ10 mL/kg) and fewer non-ARDS sepsis patients with elevated EVLW. Daily measurements represent individual EVLW measurements stratified by whether ARDS was confirmed present by American-European Consensus Conference criteria on that day (daily ARDS) or whether ARDS was absent on that day. For daily ARDS measurements, indexing EVLW to PBW or AdjBW results in a significantly greater proportion of measurements with elevated EVLW; daily measurements in patients without ARDS led to nonsignificant changes in EVLW measurements a Change compared to EVLW indexed to ActBW. b Daily ARDS means that ARDS was confirmed each day with simultaneous measurement of EVLW. figure) and median EVLW increased most when indexing EVLW to predicted body weight (PBW) followed by adjusted body weight (AdjBW). Normal EVLW is Յ10 mL/kg. tion of ARDS patients with elevated EVLW while reducing the proportion of non-ARDS sepsis patients with elevated EVLW, as would be expected clinically. Therefore, the conventional method of indexing to ActBW may misclassify both ARDS and non-ARDS patients, and recalculating EVLW using PBW may improve the diagnosis of ARDS in critically ill patients.
We additionally examined the relationship between oxygenation (PaO 2 /FIO 2 ratio) or severity of lung damage (LIS) and the various methods of indexing EVLW in patients with ARDS. We found a much stronger relationship between EVLW indexed to PBW and either LIS or oxygenation compared with EVLW indexed to other weights. Both LIS and oxygenation are routinely measured in ARDS patients to determine severity and progression of disease. The improved correlation to LIS and oxygenation when EVLW is indexed to PBW further demonstrates the superiority of this method over indexing EVLW to actual body weight.
Only a minority of ARDS patients are expected to have normal EVLW due to alveolar-capillary barrier dysfunction and impaired fluid clearance inherent in the disease process (5) . We found that 23% of patients with ARDS had normal EVLW when indexed to ActBW, which is consistent with previous studies (9 -12) that reported 21% to 35% of ARDS patients with normal EVLW. These findings reflect the imperfection in the current calculation of EVLW using actual body weight, and the current data suggest that the method for measuring EVLW can be improved by simply adopting a more appropriate method for indexing EVLW. As height and gender are the main components in determining lung volumes (13, 14) , excess body weight should not influence extravascular capacity of the lungs. Therefore, calculations of PBW and AdjBW, which use height and gender as the main determinants of body weight, may favorably influence indexing EVLW for categorization of ARDS and non-ARDS sepsis patients and better correlate with oxygenation and lung injury.
The findings of our study have both prognostic and therapeutic implications. EVLW has been found to be an independent predictor of survival in the ICU with mortality Ͼ60% when EVLW exceeds 10 mg/kg (9, 22, 27) . The current method for calculating EVLW may underestimate the degree of lung water in ARDS patients. Changing the method for indexing EVLW will improve our prognostic capabilities by providing more accurate estimations of lung edema in ARDS patients. EVLW measurements have been used therapeutically to assist in fluid management with subsequent decreases in duration of mechanical ventilation and ICU length of stay (36, 37) . There are case reports of relevant changes in clinical management based on re-indexing of EVLW (38) . Imprecise measurements of EVLW using actual body weight may equally have adverse therapeutic ramifications.
There are important limitations to this study. There is no consensus for an abnormal level of EVLW. We have chosen the common 10 mL/kg as a cutoff for normal EVLW (9, (23) (24) (25) (26) (27) , although others have also used 7 mL/kg (10, 11, 36, 37) . We used the higher threshold to be more strict in classifying cases of elevated EVLW, as in previous studies (9, (23) (24) (25) (26) (27) . If the lower threshold was used, more cases of elevated EVLW would potentially be identified in the non-ARDS sepsis group. This, however, would cause a misclassification of severe sepsis patients to elevated lung water that may not be clinically justified. Similarly, although the AECC definition for ARDS is an accepted international standard, it captures a heterogeneous group of patients. To mitigate these effects, we compared three different measurements of body weight to equally consider the accuracy of each, and we included patients with both ARDS and non-ARDS (controls) to examine the clinical relevance of any observed changes. In addition, this relatively small study found important and clinically relevant differences in EVLW depending on body weight index, thus diminishing concerns about sample size.
Another limitation is the baseline anthropometric imbalance between the ARDS and non-ARDS sepsis patients in this study. ARDS patients on average were 8 cm taller and weighed 13 kg more than non-ARDS sepsis patients. The difference is attributed the small sample size as there is no physiologic explanation for this in ARDS. As calculations for PBW and AdjBW are all dependent on height, the difference between groups persisted across these values as well. Despite these baseline differences, the study data and its interpretation should not be affected. As this was not a therapeutic study, the classification of patients into ARDS or non-ARDS sepsis categories did not affect how patients were treated or how data were collected. The groupings merely served as a basis for comparison to show that adjusting EVLW was not haphazard; that is, in patients with ARDS, EVLW was elevated in nearly all patients after adjusting body weights, whereas in non-ARDS patients, the number of patients with normal EVLW increased. Furthermore, after adjustment for baseline differences in height and actual body weight using multivariate regression modeling, the study results remained unchanged. Finally, race is also a predictor of lung size as evidenced by smaller lung volumes in African Americans for a given height and gender (39) . The smaller predicted lung volumes could lead to a global underestimation of EVLW in our predominantly African American population; however, this affect is minor compared with the influence of gender and height and thus should not significantly influence the study results.
CONCLUSION
Indexing EVLW to body weight that is based on height (predicted or adjusted body weight) rather than ActBW improved the classification of ARDS patients with elevated EVLW and had a neutral or beneficial effect on the classification of severe sepsis patient without ARDS. Adjusting EVLW to reflect height and gender rather than body weight is justified in clinical practice, as it is well known that height and gender are the main predictors of lung volume. EVLW measurements indexed to PBW or AdjBW correlate better to patient oxygenation and lung injury score than do measurements indexed to ActBW. Precise measurements of EVLW are important as they are used for prognostic purposes and could be the basis for therapeutic interventions. Further investigation is required to confirm these findings and to determine whether additional hemodynamic and volumetric variables need to be similarly recalculated.
